A med tech with a screening device to help cancer survivors topped this week’s charts. The chasing pack all have an interest in the green energy revolution with one catching the eye of a global giant.
FLASHPOINT - TRANSCRIPT
Tim - Here's Matt Birney with the ASX Runners of the Week. Thanks to CPS Capital.
Matt Birney - Thanks Tim. Well, shares in medical device company Impedimed soared 129 per cent this week. Its medical devices gaining attention after the procedure they undertake was officially recommended to screen for side effects of cancer treatments. Impedimed vaulted to 13.5 cents up from 5.9.
Matt Birney - Mamba Exploration locked onto wide zones of clay-based rare earths in WA's Wheatbelt, rocketing 110 per cent. Its shares touching 16 cents up from 7.6 last week.
Matt Birney - Infinity Lithium locked down a hard-fought approval for its Spanish lithium project, resulting in its biggest share trading frenzy in over a year. Infinity's stock almost doubled to hit 18.5 cents.
Matt Birney - And finally Liontown set pulses racing in the lithium world when it rejected a 5.5 billion dollar takeover bid from New York-listed industry giant Albemarle. Regardless, its share price still roared to 2.67 from a 1.49.
Matt Birney - Albemarle is now trying to get hold of Liontown share register which tells me the 26 billion US dollar gorilla might just be lining up for another swing at the lion.
#BullsNBearsWA #TheWestAustralian #Flashpoint #ASX #CPSCapital #Channel7 $IPD #IPD #ImpediMedLimited $M24 #M24 #MambaExploration $INF #INF #InfinityLithium $LTR #LTR #LiontownResources #AlbermaleCorp
Kommentare